EVOCOR 2.5 MG BOX OF 30

Treatment of stable, moderate to severe chronic heart failure with reduced systolic ventricular function (ejection fraction ≤ 35%, as determined by echocardiography), as an adjunct to angiotensin-converting enzyme (ACE) inhibitors and diuretics, and optionally digitalis.

Category: Tag:

Description

Specialty EVOCOR
Dosage 2.5 mg
Form Film-coated tablet
Presentation B/30
Primary Packaging Blister
Specification ALU, PVC, PVDC
INN BISOPROLOL
VEIC Classification Essential
Therapeutic Class CARDIOVASCULAR SYSTEM
Subclass BETA-BLOCKING AGENTS
Laboratory PHILADELPHIA PHARMA
Schedule A
Shelf Life 24 (months)
Generic/Brand Generic
Marketing Authorization 9353173
Marketing Authorization Date 2017-01-25
Range Cardio Metabolic

Reviews

There are no reviews yet.

Be the first to review “EVOCOR 2.5 MG BOX OF 30”

Your email address will not be published. Required fields are marked *